Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series

Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.
No abstract available

Keywords: COVID-19; autoimmune diseases; vaccination.

Publication types

  • Letter
  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / immunology*
  • Female
  • Humans
  • Immunity, Humoral / drug effects*
  • Male
  • Middle Aged
  • Musculoskeletal Diseases / drug therapy
  • Musculoskeletal Diseases / immunology*
  • Musculoskeletal Diseases / virology
  • Mycophenolic Acid / administration & dosage*
  • Mycophenolic Acid / immunology
  • Prospective Studies
  • Rheumatic Diseases / drug therapy
  • Rheumatic Diseases / immunology*
  • Rheumatic Diseases / virology
  • SARS-CoV-2 / immunology
  • Withholding Treatment*
  • Young Adult

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Mycophenolic Acid